ClinicalTrials.gg

Menarini Group clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 81 studies whose lead sponsor is Menarini Group or one of 10 companies grouped under it. 14 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 12, 2026.

Our grouping of 12 registry names, not the registry’s. See them and correct one ↓

Compare Menarini Group with CSPC Pharmaceutical Group and AstraZeneca →

Pipeline: 7 programs

Each counted once: 7 with a study Menarini Group leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Menarini Group’s own registered studies; Menarini Group’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Menarini Group’s studies test, most open studies first — 27 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 17 more

Coming up

7 of Menarini Group’s studies under way reach primary completion within a year, 1 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 2D
  3. 1J’27
  4. F
  5. M
  6. A
  7. 1M
  8. J
  9. J
  10. A
  11. S
  12. 2O
  13. N

Add all 7 to your calendar (.ics) → With an account.

All 81 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1417%Recruiting 12 · Not yet recruiting 2
  • Under way, not recruiting79%
  • Completed4657%
  • Stopped early1114%Terminated 9 · Withdrawn 2
  • Status unknown or other34%

Phase

Where

  • Italy31
  • United States28
  • Spain23
  • Germany21
  • Poland17
  • United Kingdom16

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 714
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 626

By the year each study started; 3 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Menarini Group.

  • Menarini Group
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    28 studies
  • Stemline Therapeutics, Inc.
    Acquired — became part of Menarini Group, Jun 10, 2020 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    23 studies →
  • Berlin-Chemie AG Menarini Group
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • Menarini International Operations Luxembourg SA
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    8 studies →
  • A.Menarini Asia-Pacific Holdings Pte Ltd
    Acquired — became part of Menarini Group, 2011 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    5 studies →
  • A. Menarini Industrie Farmaceutiche Riunite S.r.l.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies
  • Menarini Silicon Biosystems, INC
    Acquired — became part of Menarini Group, 2013 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • A. Menarini International Licensing S.A.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Menarini Silicon Biosystems
    Acquired — became part of Menarini Group, 2013 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Menarini (Thailand) Limited
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Menarini Biomarkers Singapore
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Berlin-Chemie Menarini
    Acquired
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Menarini Group leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 81. Browse all 81 →